Aprepitant (Sandoz Inc)
Welcome to the PulseAid listing for the Aprepitant drug offered from Sandoz Inc. This Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A4 Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sandoz Inc |
| NON-PROPRIETARY NAME: | aprepitant |
| SUBSTANCE NAME: | APREPITANT |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A4 Inducers [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-12-27 |
| END MARKETING DATE: | 0000-00-00 |
Aprepitant HUMAN PRESCRIPTION DRUG Details:
| Item Description | Aprepitant from Sandoz Inc |
| LABELER NAME: | Sandoz Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 40(mg/1) |
| START MARKETING DATE: | 2016-12-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0781-2321_bd32527e-b2df-44ac-a6bb-21be96d47906 |
| PRODUCT NDC: | 0781-2321 |
| APPLICATION NUMBER: | ANDA090999 |
Other APREPITANT Pharmaceutical Manufacturers / Labelers:
